Withdrawing From Psychiatric Drugs: How to Produce Smaller Doses Than Those the Drug Companies Provide
Peter Gøtzsche: To reduce the risk of withdrawal symptoms, it is necessary to respect the form of the binding curve.
Stay updated with breaking news from User Research Centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Peter Gøtzsche: To reduce the risk of withdrawal symptoms, it is necessary to respect the form of the binding curve.
"The insurance companies, the patients, and the doctors are addicted to the tablets. So we are all stuck in the system. And only if you put the health of the patient as the purpose of your treatment can you change it.” ~ Pharmacist Paul Harder
New strategies for tapering psychiatric drugs achieved by acknowledging withdrawal symptoms and valuing service-users’ first-hand knowledge.
Jim van Os and Peter Groot discuss their paper: “Successful Use of Tapering Strips for Hyperbolic Reduction of Antidepressant Dose: A Cohort Study”